Rheumatology (Oxford)
http://www.ncbi.nlm.nih.gov/pubmed/17363399
46(5):887-8
https://connects.catalyst.harvard.edu/Profiles/profile/490918
Development of active tuberculosis following initiation of infliximab despite appropriate prophylaxis.
Rheumatology (Oxford)
http://www.ncbi.nlm.nih.gov/pubmed/17363399
46(5):887-8
https://connects.catalyst.harvard.edu/Profiles/profile/490918